In contrast, CAMKMT and METTL18 both promoted tumor activity, but through different mechanisms: CAMKMT directly interacted with and likely methylated Src (detailed Src activation mechanisms by CAMKMT are currently being explored, data not shown), while METTL18 did not directly bind to Src (Fig. 4A). Here, METTL18 is linked to neoplasm.